Ireland
--:--IST
Starting soon Not applicable

Effect of Shock Wave Therapy on Myofascial Pain Syndrome in Adolescent Athletes

NCT06845475 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-02-25
Last updated
2025-02-25

Condition(s) studied

Myofascial Pain Syndrome

Investigational drug(s) / intervention(s)

Designed physical therapy programExtracorporeal shock wave therapy (ESWT)

Designed physical therapy program: Both groups will receive a designed physical therapy program, in the form of myofascial trigger points pressure release, stretching of the upper trapezius muscle, strengthening exercises, and infrared radiation for 4 weeks.

Extracorporeal shock wave therapy (ESWT): Adolescents of the experimental group will receive Extracorporeal shock wave therapy with the following parameters; low-level energy radial extracorporeal shock wave by (STORZ MEDICAL Master Pulse MP200), each subject received 3 sessions per week for 4 weeks with 700 impulse/session 400 impulse was applied to tight band and 300 impulses will be applied surrounding the tight band, with frequency \[10HZ\], resulting in positive energy flux density \[EFD\] 0.056mJ/mm.

Study summary

The purpose of the study is to determine the effect of extracorporeal shockwave therapy on pain, neck range of motion, and functional activity in adolescent athletes.

Eligibility

Sex
ALL
Min age
14 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * Age ranges from 14 to 18 years. * All adolescents have regional pain complaint. * Tenderness in cervical trigger points in the midpoint of the upper border of the trapezius muscle, from grade 2 to grade 4 according to the tenderness grading scheme (Hubbard, 1993) (Appendix II). * Palpation of a trigger point elicits a stereotypic zone of referred pain specific to that muscle. * Identification of a palpable taut band, as well as a palpable, and exquisitely tender spot along the length of that taut band. * All adolescents are allowed to practice their regular sports activities. Exclusion Criteria: * Dermatological disorders. * Having myofascial trigger points injection. * Chronic pain in both sides of the body. * History of findings of cervical injury whether orthopedic or soft tissue injury. * Analgesic drugs or NSAIDs during the treatment period.

Primary outcome measure(s)

  • Assessment of pain level — 4 weeks
    By Pain Quality Assessment Scale (PQAS), which help to measure different aspects of pain. For one patient, a pain might feel extremely hot and burning, but not at all dull, while another patient may not experience any burning pain, but feel like their pain is very dull and achy. High test-retest reliability has been observed in both literate and illiterate patients with neuropathic pain, for construct validity, was high in patients with chronic pain conditions. The scale creates a 20- item measures that would be even more useful for assessing neuropathic pain and also would be used to assess pain qualities associated with non-neuropathic pain. PQAS can be scored as individual ratings (20 items), or the PQAS items can be combined into composite scores.

Trial sites (1)

FacilityCityRegionStatus
Ismailia Medical Complex Ismailia Egypt
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06845475 on ClinicalTrials.gov ↗ ← All trials in Egypt